Kintsugi
Founded Year
2019Stage
Series A | AliveTotal Raised
$28.38MLast Raised
$20M | 1 yr agoAbout Kintsugi
Kintsugi develops and offers smarter mental healthcare infrastructure using voice biomarkers to streamline access to care. It detects signs of clinical depression and anxiety using machine learning and voice biomarkers. The company was founded in 2019 and is based in Berkeley, California.
Kintsugi's Product Videos
ESPs containing Kintsugi
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The voice biomarkers — mental health market is a growing field that utilizes voice analysis technology to detect and monitor mental health conditions. This technology can analyze various vocal characteristics such as tone, pitch, and rhythm to identify potential indicators of mental health issues such as depression, anxiety, and stress. The solutions offered by this market can provide early detect…
Kintsugi named as Highflier among 10 other companies, including Innovaccer, Sonde Health, and Linus Health.
Compete with Kintsugi?
Ensure that your company and products are accurately represented on our platform.
Research containing Kintsugi
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Kintsugi in 1 CB Insights research brief, most recently on Dec 7, 2022.
Expert Collections containing Kintsugi
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Kintsugi is included in 10 Expert Collections, including Mental Health Tech.
Mental Health Tech
1,410 items
This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.
Wellness Tech
1,370 items
We define wellness tech as companies developing technology to help consumers improve their physical, mental, and social well-being. Companies in this collection play across a wide range of categories, including food and beverage, fitness, personal care, and corporate wellness.
Artificial Intelligence
10,624 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Beauty & Personal Care
858 items
These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.
Health Monitoring & Diagnostics
2,623 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Digital Health
11,223 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma companies and and assistive tech developers.
Latest Kintsugi News
Mar 21, 2023
Kintsugi Thinking Kintsugi thinking means reframing mistakes as learning opportunities. Mistakes are only failures when we don’t learn from them. By reframing our approach to mistakes, we can fail our way to success. The more we expose ourselves to making mistakes in the pursuit of progress, the more opportunity we give ourselves to learn. How we react to failure has an immense impact on others, from a parent’s reaction to a child’s mistake to the leader of one of the most successful organizations of all time. When we embrace mistakes as learning outcomes, we can uncover new capabilities, new innovations, and new opportunities. It is key to remember that there are always assets in the ashes. 0
Kintsugi Frequently Asked Questions (FAQ)
When was Kintsugi founded?
Kintsugi was founded in 2019.
Where is Kintsugi's headquarters?
Kintsugi's headquarters is located at 1569 Solano Avenue, Berkeley.
What is Kintsugi's latest funding round?
Kintsugi's latest funding round is Series A.
How much did Kintsugi raise?
Kintsugi raised a total of $28.38M.
Who are the investors of Kintsugi?
Investors of Kintsugi include Acrew Capital, Darling Ventures, WellFound, Side Door Ventures, Alpha Edison and 16 more.
Who are Kintsugi's competitors?
Competitors of Kintsugi include aiberry, Winterlight Labs, Mindstrong, Deliberate AI, Canary Speech and 8 more.
Compare Kintsugi to Competitors
Ellipsis Health develops artificial intelligence (AI) generated vocal biomarker technology. It helps in identifying, assessing, and monitoring mental health with a short voice sample, its technology determines the severity of anxiety and depression. Ellipsis Health was founded in 2017 and is based in San Francisco, California.
Aural Analytics uses speech to detect subtle but clinically meaningful changes in brain health. The platform is completely agnostic to disease, device, location and language and powers applications throughout the world. Aural Analytics was founded in 2015 and is based in Scottsdale, Arizona.
Sonde Health is a health technology company that provides voice-enabled symptom detection and monitoring platform for chronic and mental health conditions. The platform analyzes vocal features that reflect changes in a user's voice caused by changing physiology of their body due to symptoms of the disease. The company was founded in 2015 and is based in Boston, Massachusetts.
Modality.AI detects health conditions using conversational AI. The company's platform analyzes the video of a user, recorded while the user interacts with an on-screen avatar, for facial movements and speech patterns to evaluate changes in neurological diseases to assess neurological and psychiatric states. Its platform can be used in clinics by physicians or as a point-of-care at home. It was founded in 2018 and is based in San Francisco, California.
Darmiyan develops fully automated proprietary software that inputs human brain MRIs. It produces maps that detect Alzheimer's disease up to fifteen years before symptoms. The company technology provides a platform for presymptomatic diagnosis of neurodegenerative disorders, with precise quantification and localization of microscopic abnormality in the brain. It was founded in 2016 and is based in Berkeley, California.
Feel Therapeutics develops biomarkers and digital therapeutics to change the way mental health is diagnosed, managed, and cared for. The company develops wristbands with integrated sensors that measure a variety of bio-signals. The connected mobile app provides personalized recommendations and coaching to help users improve emotional well-being, as well as physiological and digital biomarkers and metrics. The company is a direct-to-consumer firm that is aimed at patients with Major Depressive Disorder and/or Generalized Anxiety Disorder. The company primarily partners with pharmaceutical companies, to advance their clinical development, RWE, and commercialization strategies. It was formerly known as Myfeel and Sentio Solutions. It was founded in 2015 and is based in San Francisco, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.